CD44 and hepatocellular carcinoma: The attenuation or even loss in the response to galunisertib in CD44knockdown cells indicate that down-regulation of CD44 by galunisertib may be one of the relevant mechanisms undergoneby this drug to mediate its effects on stemness and invasion in HCC cells.